These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 25257578)

  • 1. PI3KCA in ovarian clear cell carcinoma-reply.
    Nakayama K; Kyo S
    Hum Pathol; 2014 Dec; 45(12):2515. PubMed ID: 25257578
    [No Abstract]   [Full Text] [Related]  

  • 2. PIK3CA in ovarian clear cell carcinoma.
    Zannoni GF; Improta G; Fraggetta F
    Hum Pathol; 2014 Dec; 45(12):2514. PubMed ID: 25245602
    [No Abstract]   [Full Text] [Related]  

  • 3. PIK3CA mutations in ovarian cancer.
    Campbell IG; Russell SE; Phillips WA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7042; author reply 7042-3. PubMed ID: 16203798
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Ishikawa M; Katagiri A; Iida K; Nakayama S; Otsuki Y; Shih IeM; Miyazaki K
    Hum Pathol; 2012 Dec; 43(12):2197-206. PubMed ID: 22705003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma.
    Jiang G; Huang Z; Zhang S; Wang L
    Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients.
    Zannoni GF; Improta G; Pettinato A; Brunelli C; Troncone G; Scambia G; Fraggetta F
    J Clin Pathol; 2016 Dec; 69(12):1088-1092. PubMed ID: 27153872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
    Yamamoto S; Tsuda H; Takano M; Iwaya K; Tamai S; Matsubara O
    J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian clear cell carcinoma--bad endometriosis or bad endometrium?
    Gounaris I; Charnock-Jones DS; Brenton JD
    J Pathol; 2011 Oct; 225(2):157-60. PubMed ID: 21898874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
    Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
    Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry.
    Dodds T; D'Urso L; Gill AJ
    Pathology; 2015 Oct; 47(6):591-3. PubMed ID: 26308139
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma.
    Itamochi H; Oishi T; Oumi N; Takeuchi S; Yoshihara K; Mikami M; Yaegashi N; Terao Y; Takehara K; Ushijima K; Watari H; Aoki D; Kimura T; Nakamura T; Yokoyama Y; Kigawa J; Sugiyama T
    Br J Cancer; 2017 Aug; 117(5):717-724. PubMed ID: 28728166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1).
    Jiang W; Ye S; Xiang L; Yang W; He T; Pei X; Guo L; Yang H
    J Ovarian Res; 2018 Jul; 11(1):58. PubMed ID: 29986747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic analysis of endometriosis and ovarian cancer].
    Obata K; Hoshiai H
    Nihon Rinsho; 2001 Jan; 59 Suppl 1():217-20. PubMed ID: 11235170
    [No Abstract]   [Full Text] [Related]  

  • 14. Endometriosis-associated ovarian carcinomas.
    Nissenblatt M
    N Engl J Med; 2011 Feb; 364(5):482-3; author reply 484-5. PubMed ID: 21288105
    [No Abstract]   [Full Text] [Related]  

  • 15. The origin of ovarian cancer—is it getting clearer?
    Birrer MJ
    N Engl J Med; 2010 Oct; 363(16):1574-5. PubMed ID: 20942676
    [No Abstract]   [Full Text] [Related]  

  • 16. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 mutation is infrequent in clear cell carcinoma of the ovary.
    Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
    Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An "ariditary" form of ovarian cancer].
    Birnbaum DJ; Sabatier R; Mamessier É; Birnbaum D; Bertucci F
    Med Sci (Paris); 2010 Dec; 26(12):1040-2. PubMed ID: 21187041
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes.
    Sekizawa A; Amemiya S; Otsuka J; Saito H; Farina A; Okai T; Tachikawa T
    Med Electron Microsc; 2004 Jun; 37(2):97-100. PubMed ID: 15221651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
    Huang HN; Huang WC; Lin CH; Chiang YC; Huang HY; Kuo KT
    Hum Pathol; 2014 Nov; 45(11):2318-25. PubMed ID: 25281027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.